The Europe diabetic foot ulcer treatment market size is expected to reach USD 2.3 billion by 2030, registering a CAGR of 5.4%.Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years. Many adjuvant therapies, such as nonsurgical debridement agents, dressings & topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies, are said to effectively improve and cure DFU.
Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme, allows the body to heal the wound at a quicker rate. The biologics segment held the largest revenue share in 2021 and is projected to expand further at the fastest CAGR during the forecast period. Biologics include growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF), stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation & circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share, followed by therapy devices and antibiotic medications, in 2021. Industry players are constantly developing new and improved products to ensure quicker healing time for DFU.
This product will be delivered within 1-3 business days.
Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme, allows the body to heal the wound at a quicker rate. The biologics segment held the largest revenue share in 2021 and is projected to expand further at the fastest CAGR during the forecast period. Biologics include growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF), stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation & circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share, followed by therapy devices and antibiotic medications, in 2021. Industry players are constantly developing new and improved products to ensure quicker healing time for DFU.
Europe Diabetic Foot Ulcer Treatment Market Report Highlights
- The biologics treatment segment led the industry and accounted for the largest share in 2021 due to reduced wound healing time and increased platelet formation efficiency of biologics treatment
- Germany accounted for the largest revenue share owing to the presence of the highest number of diabetic patients
- Despite the COVID-19 pandemic, leading players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from COVID-19 infection
- The market was said to increase at a steady rate in 2021, as COVID-19-treated patients witnessed a rise in sugar levels leading to the onset of diabetes
- For instance, the overall proportion of patients with diabetes with COVID-19 ranged from 5% to 30% in Italy during 2020
- Furthermore, Smith and Nephew reported the sales of their newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020
- Thus, the industry grew dramatically in 2020 and is estimated to stabilize during the forecast period
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Diabetic Foot Ulcer Treatment Market: Disease Primer & Epidemiology
Chapter 5 Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis
Chapter 6 Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis
Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis, by Treatment, Ulcer Type
Chapter 8 Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ConvaTec, Inc.
- Acelity L.P. Inc.
- 3M Healthcare
- Coloplast Corp
- Smith & Nephew Plc
- B Braun Melsungen AG
- Medline Industries, Inc.
- Organogenesis, Inc.
- Molnlycke Health Care AB
- Medtronic
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | July 2022 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.3 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 10 |
